日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Anlotinib ameliorates myositis-associated interstitial lung disease (MAILD) via suppression of the NETs-PI3K/Akt-driven epithelial-mesenchymal transition.

安罗替尼通过抑制NETs-PI3K/Akt驱动的上皮-间质转化来改善肌炎相关间质性肺病(MAILD)。

Yang Jumei, Chai Hui, Zhu Jiarui, Cui Xi, Li Wenjun, Su Qiyan, Guo Zhen, Feng Yingyue, Zhang Sigong

Pirfenidone alleviates interstitial lung disease in mice by inhibiting neutrophil extracellular trap formation and NLRP3 inflammasome activation.

吡非尼酮通过抑制中性粒细胞胞外陷阱的形成和 NLRP3 炎症小体的激活来缓解小鼠的间质性肺病

Su Qiyan, Feng Yingyue, Guo Jin, Cui Xi, Zhu Jiarui, Yang Jumei, Zhang Sigong

Advances in the Study of the Pathology and Treatment of Alzheimer's Disease and Its Association with Periodontitis

阿尔茨海默病病理学和治疗研究进展及其与牙周炎的关系

Tang, Dan; Sun, Chang; Yang, Jumei; Fan, Lili; Wang, Yonggang

Rapid screening for antigenic characterization of GII.17 norovirus strains with variations in capsid gene

快速筛选具有衣壳基因变异的 GII.17 诺如病毒株的抗原特征

Yingyin Liao, Liang Xue, Junshan Gao, Yueting Zuo, Yanhui Liang, Yueting Jiang, Weicheng Cai, Jiale Yang, Jumei Zhang, Yu Ding, Moutong Chen, Aiwu Wu, Xiaoxia Kou, Qingping Wu

A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway

新型磷酰胺化合物 DCZ0805 通过 NF-κB 通路表现出强效抗骨髓瘤活性

Xuejie Gao #, Bo Li #, Anqi Ye #, Houcai Wang, Yongsheng Xie, Dandan Yu, Zhijian Xu, Bingqing Shi, Hui Zhang, Qilin Feng, Ke Hu, Yong Zhang, Cheng Huang, Guang Yang, Jumei Shi, Weiliang Zhu

Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma

布鲁顿酪氨酸激酶是多发性骨髓瘤干细胞的治疗靶点

Ye Yang, Jumei Shi, Zhimin Gu, Mohamed E Salama, Satyabrata Das, Erik Wendlandt, Hongwei Xu, Junwei Huang, Yi Tao, Mu Hao, Reinaldo Franqui, Dana Levasseur, Siegfried Janz, Guido Tricot, Fenghuang Zhan

RARα2 expression confers myeloma stem cell features

RARα2 表达赋予骨髓瘤干细胞特征

Ye Yang, Jumei Shi, Giulia Tolomelli, Hongwei Xu, Jiliang Xia, He Wang, Wen Zhou, Yi Zhou, Satyabrata Das, Zhimin Gu, Dana Levasseur, Fenghuang Zhan, Guido Tricot